These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36736328)

  • 1. In vitro and ex vivo experimental models for evaluation of intranasal systemic drug delivery as well as direct nose-to-brain drug delivery.
    Haasbroek-Pheiffer A; Van Niekerk S; Van der Kooy F; Cloete T; Steenekamp J; Hamman J
    Biopharm Drug Dispos; 2023 Feb; 44(1):94-112. PubMed ID: 36736328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Versatile Nanoparticulate Systems as a Prosperous Platform for Targeted Nose-Brain Drug Delivery.
    Taha E; Shetta A; Nour SA; Naguib MJ; Mamdouh W
    Mol Pharm; 2024 Mar; 21(3):999-1014. PubMed ID: 38329097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting.
    Wong CYJ; Baldelli A; Tietz O; van der Hoven J; Suman J; Ong HX; Traini D
    Int J Pharm; 2024 Apr; 654():123922. PubMed ID: 38401871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery systems from nose to brain.
    Misra A; Kher G
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2355-79. PubMed ID: 23016642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into direct nose to brain delivery: current status and future perspective.
    Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
    Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
    Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
    Shinde RL; Bharkad GP; Devarajan PV
    Eur J Pharm Biopharm; 2015 Oct; 96():363-79. PubMed ID: 26318978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
    Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
    J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can nasal drug delivery bypass the blood-brain barrier?: questioning the direct transport theory.
    Merkus FW; van den Berg MP
    Drugs R D; 2007; 8(3):133-44. PubMed ID: 17472409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway.
    Chen Y; Zhang C; Huang Y; Ma Y; Song Q; Chen H; Jiang G; Gao X
    Adv Drug Deliv Rev; 2024 Apr; 207():115196. PubMed ID: 38336090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational,
    Boyuklieva R; Zagorchev P; Pilicheva B
    Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nose-to-brain delivery of nanotherapeutics: Transport mechanisms and applications.
    Xu K; Duan S; Wang W; Ouyang Q; Qin F; Guo P; Hou J; He Z; Wei W; Qin M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1956. PubMed ID: 38558503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to facilitate or block nose-to-brain drug delivery.
    Martins PP; Smyth HDC; Cui Z
    Int J Pharm; 2019 Oct; 570():118635. PubMed ID: 31445062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration.
    Kadakia E; Bottino D; Amiji M
    Pharm Res; 2019 Mar; 36(5):75. PubMed ID: 30923914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of intranasal delivery route of drug administration for brain targeting.
    Erdő F; Bors LA; Farkas D; Bajza Á; Gizurarson S
    Brain Res Bull; 2018 Oct; 143():155-170. PubMed ID: 30449731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct nose-to-brain delivery of lamotrigine following intranasal administration to mice.
    Serralheiro A; Alves G; Fortuna A; Falcão A
    Int J Pharm; 2015 Jul; 490(1-2):39-46. PubMed ID: 25979854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is nose-to-brain transport of drugs in man a reality?
    Illum L
    J Pharm Pharmacol; 2004 Jan; 56(1):3-17. PubMed ID: 14979996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
    Pardeshi CV; Belgamwar VS
    Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical and physiological considerations for efficient nose-to-brain targeting.
    Bahadur S; Pathak K
    Expert Opin Drug Deliv; 2012 Jan; 9(1):19-31. PubMed ID: 22171740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.